These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 15999700)

  • 1. [General concept and epidemiology of diabetic retinopathy].
    Hori S
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():161-4. PubMed ID: 15999700
    [No Abstract]   [Full Text] [Related]  

  • 2. [Roles of cytokines and growth factors in diabetic retinopathy].
    Yamashita H; Yamamoto T
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():202-6. PubMed ID: 15999707
    [No Abstract]   [Full Text] [Related]  

  • 3. Vascular endothelial growth factor and diabetic retinopathy: pathophysiological mechanisms and treatment perspectives.
    Caldwell RB; Bartoli M; Behzadian MA; El-Remessy AE; Al-Shabrawey M; Platt DH; Caldwell RW
    Diabetes Metab Res Rev; 2003; 19(6):442-55. PubMed ID: 14648803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiopoietin modulation of vascular endothelial growth factor: Effects on retinal endothelial cell permeability.
    Peters S; Cree IA; Alexander R; Turowski P; Ockrim Z; Patel J; Boyd SR; Joussen AM; Ziemssen F; Hykin PG; Moss SE
    Cytokine; 2007 Nov; 40(2):144-50. PubMed ID: 17959386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pathology of diabetic retinopathy].
    Hata Y; Ishibashi T
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():165-70. PubMed ID: 15999701
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pathogenesis of diabetic macular oedema].
    Krohne TU; Fauser S; Kirchhof B; Joussen AM
    Klin Monbl Augenheilkd; 2003 Aug; 220(8):521-5. PubMed ID: 12953153
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of vascular permeability in diabetic retinopathy.
    Antonetti DA; Lieth E; Barber AJ; Gardner TW
    Semin Ophthalmol; 1999 Dec; 14(4):240-8. PubMed ID: 10758225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fundus findings and pathogenesis of diabetic macular edema].
    Funatsu H
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():269-74. PubMed ID: 15999718
    [No Abstract]   [Full Text] [Related]  

  • 9. Progression of diabetic macular edema: correlation with blood retinal barrier permeability, retinal thickness, and retinal vessel diameter.
    Sander B; Thornit DN; Colmorn L; Strøm C; Girach A; Hubbard LD; Lund-Andersen H; Larsen M
    Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):3983-7. PubMed ID: 17724176
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of advanced glycation end products and activation of PKC in diabetic retinopathy].
    Kaji Y; Oshika T
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():188-93. PubMed ID: 15999705
    [No Abstract]   [Full Text] [Related]  

  • 11. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.
    Aiello LP; Avery RL; Arrigg PG; Keyt BA; Jampel HD; Shah ST; Pasquale LR; Thieme H; Iwamoto MA; Park JE
    N Engl J Med; 1994 Dec; 331(22):1480-7. PubMed ID: 7526212
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel role of erythropoietin in proliferative diabetic retinopathy.
    Takagi H; Watanabe D; Suzuma K; Kurimoto M; Suzuma I; Ohashi H; Ojima T; Murakami T
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S62-4. PubMed ID: 17481772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term effects of intravitreal triamcinolone on retinal vascular leakage and trunk vessel diameters in diabetic macular oedema.
    Vinten M; Larsen M; Lund-Andersen H; Sander B; La Cour M
    Acta Ophthalmol Scand; 2007 Feb; 85(1):21-6. PubMed ID: 17244205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral vessel leakage (PVL): a new angiographic finding in diabetic retinopathy identified with ultra wide-field fluorescein angiography.
    Oliver SC; Schwartz SD
    Semin Ophthalmol; 2010; 25(1-2):27-33. PubMed ID: 20507194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor and retinal neovascularisation: a new therapeutic approach for diabetic retinopathy.
    Favard C; Ortega N; Bayard F; Plouet J
    Diabetes Metab; 1996 Jul; 22(4):268-73. PubMed ID: 8767174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of vascular endothelial growth factor (VEGF)].
    Urban B; Peczyńska J
    Klin Oczna; 2003; 105(5):319-21. PubMed ID: 14746189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VEGF-initiated blood-retinal barrier breakdown in early diabetes.
    Qaum T; Xu Q; Joussen AM; Clemens MW; Qin W; Miyamoto K; Hassessian H; Wiegand SJ; Rudge J; Yancopoulos GD; Adamis AP
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2408-13. PubMed ID: 11527957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Herbimycin A inhibits angiogenic activity in endothelial cells and reduces neovascularization in a rat model of retinopathy of prematurity.
    McCollum GW; Rajaratnam VS; Bullard LE; Yang R; Penn JS
    Exp Eye Res; 2004 May; 78(5):987-95. PubMed ID: 15051479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitreous levels of interleukin-6 and vascular endothelial growth factor are related to diabetic macular edema.
    Funatsu H; Yamashita H; Ikeda T; Mimura T; Eguchi S; Hori S
    Ophthalmology; 2003 Sep; 110(9):1690-6. PubMed ID: 13129863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VEGF-TRAP(R1R2) suppresses choroidal neovascularization and VEGF-induced breakdown of the blood-retinal barrier.
    Saishin Y; Saishin Y; Takahashi K; Lima e Silva R; Hylton D; Rudge JS; Wiegand SJ; Campochiaro PA
    J Cell Physiol; 2003 May; 195(2):241-8. PubMed ID: 12652651
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.